Corix Bioscience (Corix Bioscience) Change In Inventory : $0.00 Mil (TTM As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Change In Inventory?

Corix Bioscience's change in inventory for the quarter that ended in Sep. 2017 was $0.00 Mil. It means Corix Bioscience's inventory stayed the same from Jun. 2017 to Sep. 2017 .

Corix Bioscience's change in inventory for the fiscal year that ended in Dec. 2016 was $0.00 Mil. It means Corix Bioscience's inventory stayed the same from Jan. 2015 to Dec. 2016 .

Corix Bioscience's Total Inventories for the quarter that ended in Sep. 2017 was $0.05 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Corix Bioscience's Inventory Turnover for the quarter that ended in Sep. 2017 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Corix Bioscience Change In Inventory Historical Data

The historical data trend for Corix Bioscience's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Change In Inventory Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

Change In Inventory

Get a 7-Day Free Trial

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Corix Bioscience Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Corix Bioscience (GREY:CXBS) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Corix Bioscience's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.0225	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Corix Bioscience's Inventory Turnover for the quarter that ended in Sep. 2017 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0.0225
	=	0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Corix Bioscience's Inventory to Revenue for the quarter that ended in Sep. 2017 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.0225	/	0
	=	N/A

Corix Bioscience Change In Inventory Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines